Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Epigenica AB is currently managing 1 pending office action. This case is assigned to 1 distinct examiner, LAFAVE, ELIZABETH ROSE, who holds the pending office action for the company. The prosecution is recorded as having 0 distinct art units. Because of this pending action, the company's immediate patent strategy is focused on the specific feedback and examination criteria of this examiner. The busiest examiner, LAFAVE, ELIZABETH ROSE, is the primary point of contact for the 1 pending action. This narrow interaction allows for a focused strategy when addressing the outstanding office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LAFAVE, ELIZABETH ROSE | 1 | 62.5% | +45.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253517 | MULTIPLEXED METHOD FOR ASSESSING GLOBAL OR GENOMIC LOCUS-SPECIFIC LEVELS OF CHROMATIN MODIFICATION | LAFAVE, ELIZABETH ROSE | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18253517 | MULTIPLEXED METHOD FOR ASSESSING GLOBAL OR GENOMIC LOCUS-SPECIFIC LEVELS OF CHROMATIN MODIFICATION | LAFAVE, ELIZABETH ROSE | — |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18253517 | MULTIPLEXED METHOD FOR ASSESSING GLOBAL OR GENOMIC LOCUS-SPECIFIC LEVELS OF CHROMATIN MODIFICATION | LAFAVE, ELIZABETH ROSE | — | §101§103§112 | Non-Final OA | — | Pending | Nov 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial